The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition.
Company to present on its ongoing Phase 1 ovarian cancer CAR-T trial
SAN JOSE, Calif., Oct. 31, 2023 /PRNewswire/ Anixa Biosciences, Inc. , a biotechnology company focused on the treatment and.
Form 8-K Cue Biopharma, Inc For: Apr 19 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The National Foundation for Cancer Research (NFCR) announced winners of the 2021 Salisbury Award Competition for Entrepreneurial Translational Research, selected from among eight semi-finalists after pitch presentations in front of a judging committee consisting of prominent cancer research scientists, clinicians, early-stage investors and business leaders.
Credit: National Foundation for Cancer Research, RadioMedix, TanoMed, Tel Aviv University, Libera Bio
ROCKVILLE, MD - The National Foundation for Cancer Research (NFCR) announced winners of the 2021 Salisbury Award Competition for Entrepreneurial Translational Research, selected from among eight semi-finalists after pitch presentations in front of a judging committee consisting of prominent cancer research scientists, clinicians, early-stage investors and business leaders.
The semi-finalists were determined earlier in the spring based upon applications from among academic laboratories or early-stage companies advancing promising experimental cancer therapeutic, diagnostic, detection and vaccine innovations.
The first prize winner of the Salisbury Award Competition is the cancer therapeutic innovation presented by Ronit Satchi-Fainaro, Ph.D., co-founder and chief scientific officer (CSO) of Israel-based TanoMed, and a professor at Tel Aviv University and director of its Cancer Bio